JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB267273

Human TXNRD3 knockout HEK-293T cell line

Be the first to review this product! Submit a review

|

(0 Publication)

TXNRD3 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 10 bp deletion in exon 9 and 1 bp insertion in exon 9.

View Alternative Names

TGR, TR-2, TRXR3_HUMAN, TXNRD3, Thioredoxin and glutathione reductase, Thioredoxin glutathione reductase, Thioredoxin reductase 2, Thioredoxin reductase 3, Thioredoxin reductase TR2

2 Images
Sanger Sequencing - Human TXNRD3 knockout HEK-293T cell line (AB267273)
  • Sanger seq

Unknown

Sanger Sequencing - Human TXNRD3 knockout HEK-293T cell line (AB267273)

Allele-2 : 1 bp insertion in exon 9.

Sanger Sequencing - Human TXNRD3 knockout HEK-293T cell line (AB267273)
  • Sanger seq

Unknown

Sanger Sequencing - Human TXNRD3 knockout HEK-293T cell line (AB267273)

Allele-1 : 10 bp deletion in exon9

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 10 bp deletion in exon 9 and 1 bp insertion in exon 9

Product details

Recommended control: Human wild-type HEK293T cell line (ab255449). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab267273-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab267273 Human TXNRD3 knockout HEK-293T cell line", "number":"AB267273-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab267273-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab267273 Human TXNRD3 knockout HEK-293T cell line", "number":"AB267273-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
TXNRD3
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

TXNRD3 also known as thioredoxin reductase 3 is an enzyme that plays a role in reducing thioredoxin proteins using NADPH as a cofactor. It typically exists as a homodimer and carries a mass of approximately 70 kDa per subunit. TXNRD3 is located in diverse tissues including testis and various other organs reflecting its versatile role in metabolism and cellular defense against oxidative stress.
Biological function summary

The enzyme functions to maintain a reduced cellular environment by reducing thioredoxin which in turn affects other cellular proteins. TXNRD3 is part of the thioredoxin system a complex that includes thioredoxin and NADPH which are essential for redox homeostasis and cellular defense mechanisms. It drives the reduction of oxidized forms of biomolecules supporting processes like DNA synthesis and repair.

Pathways

TXNRD3 significantly contributes to redox signaling and antioxidant defense. It has a pivotal position in the cellular antioxidative defense pathway by working closely with glutaredoxin and thioredoxin systems. TXNRD3 interacts with proteins such as thioredoxin helping regulate cellular redox states and protect cells from oxidative damage through these pathways. These interactions are critical for maintaining cellular functions under oxidative stress conditions.

TXNRD3 has connections with conditions involving oxidative stress and redox imbalance such as cancer. Alterations in TXNRD3 expression or activity might lead to dysregulation of redox homeostasis. In cancer the enzyme's relationship with thioredoxin and other redox-regulating proteins plays a part in tumorigenesis. Understanding TXNRD3's roles provides valuable insight into the development and progression of disease and emphasizes potential therapeutic targets for intervention.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com